90 - Impact of anti-CD20 therapy on COVID-19 in immunocompromised patients: A nationwide cohort study in Korea

Presenting Author(s)

• 

  Chan Mi Lee, MD, PhD (she/her/hers)

  Staff
  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea

  Slides

Co-Author(s)

• SK

  Suhyun Kim, n/a

  Seoul National University Hospital
  Jongno-gu, Seoul-t'ukpyolsi, Republic of Korea
• SK

  Seungyeon Kim, n/a

  Dankook University
  Cheonan, Ch'ungch'ong-bukto, Republic of Korea
• JB

  Jiyeon Bae, Graduate student

  Ewha Womans University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea
• HJ

  Hyeon Jae Jo, M.D., M.S.

  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea
• CK

  Chang Kyung Kang, MD, PhD

  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea
• PC

  Pyoeng Gyun Choe, MD, PhD

  Assistant professor
  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea
• WP

  Wan Beom Park, MD, PhD

  Professor
  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea
• NK

  Nam Joong Kim, M.D., Ph.D.

  Seoul National University College of Medicine
  Seoul, Seoul-t'ukpyolsi, Republic of Korea